Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39


Survival continues to increase in chronic lymphocytic leukaemia: a population-based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016.

van der Straten L, Levin MD, Visser O, Posthuma EFM, Doorduijn JK, Kater AP, Dinmohamed AG.

Br J Haematol. 2020 Jan 20. doi: 10.1111/bjh.16397. [Epub ahead of print] No abstract available.


Melanoma in older patients: declining gap in survival between younger and older patients with melanoma.

Schuurman MS, Hollestein LM, Bastiaannet E, Posthuma EFM, van Akkooi AJC, Kukutsch NA, Aarts MJB, Wakkee M, Lemmens VEPP, Louwman MWJ.

Acta Oncol. 2020 Jan;59(1):4-12. doi: 10.1080/0284186X.2019.1643914. Epub 2019 Jul 26.


Treatment strategies for polycythemia vera: Observations in a Dutch "real-world" cohort study.

van de Ree-Pellikaan C, de Kreuk A, Schaar CG, Beeker A, Dompeling EC, Gerrits CJH, van Houten AA, Schipperus MR, Strobbe L, Posthuma EFM, Klauke K, Westerweel PE.

Eur J Haematol. 2019 Nov;103(5):453-459. doi: 10.1111/ejh.13291. Epub 2019 Sep 5.


Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma.

Nijdam A, Dekker N, Aleman BMP, van 't Veer MB, Daniels LA, van der Maazen RW, Janus CPM, de Weijer RJ, Zijlstra JM, Stedema FG, Ta BD, Posthuma EFM, Manenschijn A, Dielwart MFH, Bilgin YM, van den Heuvel MJ, Boersma RS, van Leeuwen FE, Raemaekers JMM; BETER consortium.

Br J Haematol. 2019 Aug;186(4):e103-e108. doi: 10.1111/bjh.15936. Epub 2019 May 15. No abstract available.


High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP.

Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7. No abstract available.


Taste and smell perception and quality of life during and after systemic therapy for breast cancer.

de Vries YC, Boesveldt S, Kelfkens CS, Posthuma EE, van den Berg MMGA, de Kruif JTCM, Haringhuizen A, Sommeijer DW, Buist N, Grosfeld S, de Graaf C, van Laarhoven HWM, Kampman E, Winkels RM.

Breast Cancer Res Treat. 2018 Jul;170(1):27-34. doi: 10.1007/s10549-018-4720-3. Epub 2018 Feb 23.


Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands.

Dinmohamed AG, Posthuma EFM, Visser O, Kater AP, Raymakers RAP, Doorduijn JK.

Blood. 2018 Mar 22;131(12):1380-1383. doi: 10.1182/blood-2017-12-820381. Epub 2018 Jan 30. No abstract available.


MDS classification is improving in an era of the WHO 2016 criteria of MDS: A population-based analysis among 9159 MDS patients diagnosed in the Netherlands.

Dinmohamed AG, Visser O, Posthuma EFM, Huijgens PC, Sonneveld P, van de Loosdrecht AA, Jongen-Lavrencic M.

Cancer Epidemiol. 2017 Oct;50(Pt A):137-140. doi: 10.1016/j.canep.2017.08.016. Epub 2017 Sep 11.


Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands.

Blommestein HM, de Groot S, Aarts MJ, Vemer P, de Vries R, van Abeelen AF, Posthuma EF, Uyl-de Groot CA.

Leuk Res. 2016 Nov;50:37-45. doi: 10.1016/j.leukres.2016.09.005. Epub 2016 Sep 3.


The beneficial local and abscopal effect of splenic irradiation in frail patients with chronic lymphocytic leukaemia.

Aalbers AM, Aarts MJ, Krol AD, Marijnen CA, Posthuma EF.

Neth J Med. 2016 Mar;74(3):122-9.


Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry.

Dinmohamed AG, van Norden Y, Visser O, Posthuma EF, Huijgens PC, Sonneveld P, van de Loosdrecht AA, Jongen-Lavrencic M.

Leukemia. 2015 Dec;29(12):2449-51. doi: 10.1038/leu.2015.220. Epub 2015 Sep 15. No abstract available.


Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study.

Holtzer-Goor KM, Schaafsma MR, Joosten P, Posthuma EF, Wittebol S, Huijgens PC, Mattijssen EJ, Vreugdenhil G, Visser H, Peters WG, Erjavec Z, Wijermans PW, Daenen SM, van der Hem KG, van Oers MH, Uyl-de Groot CA.

Qual Life Res. 2015 Dec;24(12):2895-906. doi: 10.1007/s11136-015-1039-y. Epub 2015 Jul 24.


The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands.

Dinmohamed AG, van Norden Y, Visser O, Posthuma EF, Huijgens PC, Sonneveld P, van de Loosdrecht AA, Jongen-Lavrencic M.

Leuk Res. 2015 Feb;39(2):177-82. doi: 10.1016/j.leukres.2014.11.025. Epub 2014 Dec 4.


Translating the MDS flow cytometric score into clinical practice.

Heron M, Dovern E, Bakker-Jonges LE, Posthuma EF, Brouwer RE, Smedts F, Batstra MR.

Cytometry B Clin Cytom. 2015 May-Jun;88(3):207-9. doi: 10.1002/cyto.b.21208. Epub 2014 Dec 10.


Translating the MDS flow cytometric score into clinical practice.

Heron M, Dovern E, Bakker-Jonges LE, Posthuma EF, Brouwer RE, Smedts F, Batstra MR.

Cytometry B Clin Cytom. 2014 Nov 26. doi: 10.1002/cytob.21208. [Epub ahead of print] No abstract available.


Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands.

van den Broek EC, Oerlemans S, Nijziel MR, Posthuma EF, Coebergh JW, van de Poll-Franse LV.

Ann Hematol. 2015 Jan;94(1):45-56. doi: 10.1007/s00277-014-2161-6. Epub 2014 Jul 20.


Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?

van den Broek EC, Liu L, Posthuma EF, Janssen-Heijnen ML, Coebergh JW, Soerjomataram I.

Ann Hematol. 2014 Jan;93(1):157-62. doi: 10.1007/s00277-013-1929-4. Epub 2013 Oct 25.


Real-world costs of chronic lymphocytic leukaemia in the Netherlands.

Holtzer-Goor KM, Bouwmans-Frijters CA, Schaafsma MR, de Weerdt O, Joosten P, Posthuma EF, Wittebol S, Huijgens PC, Mattijssen EJ, Vreugdenhil G, Visser H, Peters WG, Erjavec Z, Wijermans PW, Daenen SM, van der Hem KG, van Oers MH, Groot CA.

Leuk Res. 2014 Jan;38(1):84-90. doi: 10.1016/j.leukres.2013.10.029. Epub 2013 Nov 8.


[Peripheral intravenous catheter-related phlebitis].

van der Sar-van der Brugge S, Posthuma EF.

Ned Tijdschr Geneeskd. 2011;155(40):A3548. Dutch.


Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008.

van den Broek EC, Kater AP, van de Schans SA, Karim-Kos HE, Janssen-Heijnen ML, Peters WG, Nooijen PT, Coebergh JW, Posthuma EF.

Eur J Cancer. 2012 Apr;48(6):889-95. doi: 10.1016/j.ejca.2011.06.053. Epub 2011 Jul 25.


Hereditary thrombocytosis not as innocent as thought? Development into acute leukemia and myelofibrosis.

Posthuma HL, Skoda RC, Jacob FA, van der Maas AP, Valk PJ, Posthuma EF.

Blood. 2010 Oct 28;116(17):3375-6. doi: 10.1182/blood-2010-06-290718. No abstract available.


Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level.

Agterof MJ, Schutgens RE, Snijder RJ, Epping G, Peltenburg HG, Posthuma EF, Hardeman JA, van der Griend R, Koster T, Prins MH, Biesma DH.

J Thromb Haemost. 2010 Jun;8(6):1235-41. doi: 10.1111/j.1538-7836.2010.03831.x. Epub 2010 Mar 3.


Appetite suppression through smelling of dark chocolate correlates with changes in ghrelin in young women.

Massolt ET, van Haard PM, Rehfeld JF, Posthuma EF, van der Veer E, Schweitzer DH.

Regul Pept. 2010 Apr 9;161(1-3):81-6. doi: 10.1016/j.regpep.2010.01.005. Epub 2010 Jan 25.


Pulmonary coccidioidomycosis: import illness and the importance of travel history.

Indhirajanti S, Maartense E, Posthuma EF, Pannekoek BJ, Vreede RW.

Neth J Med. 2009 Nov;67(10):353-5.


Improved survival for patients with large B-cell lymphoma after introduction of rituximab.

Rodenburg EM, Maartense E, Posthuma EF.

Neth J Med. 2009 Sep;67(8):355-8.


Splenectomy-induced long-term remission in a patient with multicentric Castleman's disease.

Bos MM, van den Berg LM, van Leeuwen AW, Posthuma EF.

Neth J Med. 2009 Sep;67(8):351-4.


HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.

Rutten CE, van Luxemburg-Heijs SA, Griffioen M, Marijt EW, Jedema I, Heemskerk MH, Posthuma EF, Willemze R, Falkenburg JH.

Leukemia. 2008 Jul;22(7):1387-94. doi: 10.1038/leu.2008.90. Epub 2008 Apr 17.


Prevention of vitamin and mineral deficiencies after bariatric surgery: evidence and algorithms.

Schweitzer DH, Posthuma EF.

Obes Surg. 2008 Nov;18(11):1485-8. doi: 10.1007/s11695-008-9489-8. Epub 2008 Mar 28. Review.


Proteosomal degradation of BCR/ABL protein can generate an HLA-A*0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated.

Posthuma EF, van Bergen CA, Kester MG, de Paus RA, van Veelen PA, de Ru AH, Drijfhout JW, Lurvink EG, Willemze R, Falkenburg JH.

Haematologica. 2004 Sep;89(9):1062-71.


Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.

Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.

Biol Blood Marrow Transplant. 2004 Mar;10(3):204-12.


HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.

Posthuma EF, Falkenburg JH, Apperley JF, Gratwohl A, Hertenstein B, Schipper RF, Oudshoorn M, Biezen JH, Hermans J, Willemze R, Roosnek E, Niederwieser D.

Leukemia. 2000 May;14(5):859-62.


HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.

Posthuma EF, Falkenburg JH, Apperley JF, Gratwohl A, Roosnek E, Hertenstein B, Schipper RF, Schreuder GM, D'Amaro J, Oudshoorn M, van Biezen JH, Hermans J, Willemze R, Niederwieser D.

Blood. 1999 Jun 1;93(11):3863-5.


Myelofibrosis and idiopathic thrombocytopenic purpura.

Seelen MA, de Meijer PH, Posthuma EF, Meinders AE.

Ann Hematol. 1997 Sep;75(3):129-31.


[An unusual complication of pneumococcal pneumonia: tamponade due to purulent pericarditis].

Posthuma EF, de Meijer PH, Meinders AE.

Ned Tijdschr Geneeskd. 1995 Sep 23;139(38):1913-5. Dutch. No abstract available.


Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.

Posthuma EF, Westendorp RG, van der Sluys Veer A, Kluin-Nelemans JC, Kluin PM, Lamers CB.

Gut. 1995 Feb;36(2):311-3.


Gastric outlet obstruction as a presenting manifestation of systemic lupus erythematosus.

Posthuma EF, Warmerdam P, Chandie Shaw MP, Breedveld FC, Macfarlane JD, van der Sluys Veer A, Lamers CB.

Gut. 1994 Jun;35(6):841-3.


A rare cause of a hepatic abscess: diverticulitis of the ileum.

Posthuma EF, Bieger R, Kuypers TJ.

Neth J Med. 1993 Feb;42(1-2):69-72.


Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil.

Bailey PL, Streisand JB, East KA, East TD, Isern S, Hansen TW, Posthuma EF, Rozendaal FW, Pace NL, Stanley TH.

Anesth Analg. 1990 Jan;70(1):8-15.


[Rehabilitation of the epileptic patients].

Posthuma EP.

Med Welt. 1976 Jan 16;27(3):110-3. German. No abstract available.


Supplemental Content

Loading ...
Support Center